SPLASH BEVERAGE GROUP INC

Explore how Splash Beverage Group’s CannEpil® license expands into veterinary cannabinoid therapeutics, targeting dog oncology and pain management, and how this move could drive growth and new revenue streams.

Explore why Splash Beverage Group Inc. has seen a steep decline in stock price, negative P/E ratio and operational challenges in the competitive beverage sector.